Adriana Malone (@amalone2012) 's Twitter Profile
Adriana Malone

@amalone2012

Oncologist @TischCancer (Bone Marrow Transplant), Heme/Onc & BMT felllowship PD, Senior Associate Dean for GME @MountSinaiNYC. Opinions are my own.

ID: 746355128

linkhttps://www.mountsinai.org/profiles/adriana-k-malone calendar_today09-08-2012 02:12:17

51 Tweet

247 Followers

303 Following

Carmem Bonfim (@carmembonfim1) 's Twitter Profile Photo

#GVHDday #GVHDconnect4hope #Tandem23 ASTCT CIBMTR spread the world! Connect for hope! Join the community to increase awareness for GVHD! Friday 17th February!! 🥰🥰🥰🔝🔝🔝SBTMO LABMT

#GVHDday #GVHDconnect4hope #Tandem23 <a href="/ASTCT/">ASTCT</a> <a href="/CIBMTR/">CIBMTR</a> spread the world! Connect for hope!  Join the community to increase awareness for GVHD! Friday 17th February!! 🥰🥰🥰🔝🔝🔝<a href="/SBTMO/">SBTMO</a> <a href="/LABMT2/">LABMT</a>
Hemalatha Rangarajan MD https (@hmgcoa2) 's Twitter Profile Photo

#tandem23 Dr. Chris Kanarky. 2 slide summary!. PTCY mechanism: induces functional impairment of alloreactive T cells (not quantity but quality of T cells!), increase in T regs.. mediating IST.. lower doses can be effective 25 mg/kg on day +3 and +4.#2 PCTY + alloCART! Wow!

#tandem23 Dr. Chris Kanarky. 2 slide summary!.  PTCY mechanism: induces functional impairment of alloreactive T cells (not quantity but quality of T cells!), increase in T regs.. mediating IST.. lower doses can be effective 25 mg/kg on day +3 and +4.#2 PCTY + alloCART! Wow!
Carmem Bonfim (@carmembonfim1) 's Twitter Profile Photo

#Tandem23 ASTCT CIBMTR first session by @DrMiguelPerales 🔝🔝🔝Preventing & Treating Acute GvHD in the Era of Multiple Novel Therapeutics. Prevention is still the best treatment 🥰

#Tandem23 <a href="/ASTCT/">ASTCT</a> <a href="/CIBMTR/">CIBMTR</a> first session by @DrMiguelPerales 🔝🔝🔝Preventing &amp; Treating Acute GvHD in the Era of Multiple Novel Therapeutics. Prevention is still the best treatment 🥰
Rahul Banerjee, MD, FACP (@rahulbanerjeemd) 's Twitter Profile Photo

And the poster is up - looking forward to seeing attendees (and no doubt engaging in heated debates about the last point 😉) tonight at #Tandem23 all the way in the back corner!

And the poster is up - looking forward to seeing attendees (and no doubt engaging in heated debates about the last point 😉) tonight at #Tandem23 all the way in the back corner!
Krishna Komanduri, MD, FASTCT (@drkomanduri) 's Twitter Profile Photo

Profoundly moving 😢 to see the ASTCT Public Service Award go to physicians and nurses of #Ukraine who continue stem cell transplants under impossible and heroic conditions. Watch the clip. #Tandem23 🇺🇦

ACGME (@acgme) 's Twitter Profile Photo

Now on the #ACGME Blog! Read our interview with 2023 Parker J. Palmer Courage to Teach Awardee Adriana Malone of Icahn School of Medicine at Mount Sinai The Tisch Cancer Institute. #ACGME2023 #MeaningInMedicine #MedEd acgme.org/newsroom/blog/… via ACGME

Now on the #ACGME Blog! Read our interview with 2023 Parker J. Palmer Courage to Teach Awardee <a href="/AMalone2012/">Adriana Malone</a> of <a href="/IcahnMountSinai/">Icahn School of Medicine at Mount Sinai</a> <a href="/TischCancer/">The Tisch Cancer Institute</a>. #ACGME2023 #MeaningInMedicine #MedEd acgme.org/newsroom/blog/… via <a href="/ACGME/">ACGME</a>
ACGME (@acgme) 's Twitter Profile Photo

#FYIFriday It's #ThankaResidentDay! Thank you to the amazing 150,000+ residents and fellows! Tag and share your messages of appreciation today, and thank you to the Gold Foundation for creating the day.

#FYIFriday It's #ThankaResidentDay! Thank you to the amazing 150,000+ residents and fellows! Tag and share your messages of appreciation today,  and thank you to the <a href="/GoldFdtn/">Gold Foundation</a> for creating the day.
Andre Williams (@andrewi54721839) 's Twitter Profile Photo

#GVHDDay is once a year – but for people living with Graft-versus-host disease, it’s every day. Join me in raising awareness about #GVHD and the resources and support available. Learn more at GVHDAlliance.org. #GVHDAlliance

#GVHDDay is once a year – but for people living with Graft-versus-host disease, it’s every day. 

Join me in raising awareness about #GVHD and the resources and support available. 

Learn more at GVHDAlliance.org. 

#GVHDAlliance
The Tisch Cancer Institute (@tischcancer) 's Twitter Profile Photo

Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia Vera | NEJM nejm.org/doi/full/10.10… Marina Kremyanskaya, MD, PhD; Ronald Hoffman, MD, Yelena Ginzburg, MD Icahn School of Medicine at Mount Sinai